Assessing the effect of a guideline change on drug use prevalence by including the birth cohort dimension: the case of benzodiazepines

作者: Maarten J. Bijlsma , Eelko Hak , Jens Bos , Lolkje T. W. De Jong-van den Berg , Fanny Janssen

DOI: 10.1002/PDS.3466

关键词:

摘要: Purpose The aim of this study was to investigate whether including the birth cohort dimension in time series analysis leads a more accurate estimation (long-term) effect guideline change on trend benzodiazepine use. Methods We calculated age-specific (20-84years) and sex-specific prevalence use per 1000 population quarter year (1998 2008) using prescription database set Netherlands. studied over by age group within cohorts through interrupted analyses estimate 2001. Results From 1998 2008, overall age-standardized declined from similar 54 for men 107 women 45 85 women. relative increased significantly after 2001 both sexes majority groups. Within cohorts, with until leveled thereafter. age-period approach had worse model fit indicators than within-cohort predicted larger long-term effects approach. projection estimated 36% decline whereas birth-cohort 8% decline. Conclusion Explicitly following trajectories led models better fit; conventional stronger effect. This has important implications professional practice. Copyright (c) 2013 John Wiley & Sons, Ltd.

参考文章(25)
Jennifer Glass, Krista L Lanctôt, Nathan Herrmann, Beth A Sproule, Usoa E Busto, Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits BMJ. ,vol. 331, pp. 1169- 1169 ,(2005) , 10.1136/BMJ.38623.768588.47
Masoud Amiri, Fanny Janssen, Anton E. Kunst, The decline in stomach cancer mortality: exploration of future trends in seven European countries European Journal of Epidemiology. ,vol. 26, pp. 23- 28 ,(2011) , 10.1007/S10654-010-9522-9
Alastair J.J. Wood, Richard I. Shader, David J. Greenblatt, Use of benzodiazepines in anxiety disorders. The New England Journal of Medicine. ,vol. 328, pp. 1398- 1405 ,(1993) , 10.1056/NEJM199305133281907
J. C. Ballenger, Weissmann, K. Rickels, E. M. Sellers, J. Pecknold, Schatzberg, Medication discontinuation in panic disorder. Discussion The Journal of Clinical Psychiatry. ,vol. 54, pp. 15- 24 ,(1993)
Marcel Bouvy, Rolf Van Hulten, Liset Van Dijk, Carla Van Boheemen, Katja Van Geffen, Afschaffing vergoeding heeft beperkt effect: Slechts 1 op 10 stopt nabenzomaatregel Pharmaceutisch weekblad. ,vol. 144, pp. 28- 31 ,(2009)
Gabriel Sanfélix-Gimeno, Pedro Cervera-Casino, Salvador Peiró, Beatriz González López-Valcarcel, Amparo Blázquez, Teresa Barbera, Effectiveness of safety warnings in atypical antipsychotic drugs: an interrupted time-series analysis in Spain. Drug Safety. ,vol. 32, pp. 1075- 1087 ,(2009) , 10.2165/11316520-000000000-00000
F.G. Zitman, W.J.M.J. Gorgels, M.H.M. Breteler, E.H. van de Lisdonk, A.J.J. Mol, R.C. Oude Voshaar, [Long-term use of benzodiazepines]. Nederlands Tijdschrift voor Geneeskunde. ,vol. 145, pp. 1342- 1346 ,(2001)
Eric Schirm, Taco B. M. Monster, Robin de Vries, Paul B. van den Berg, Lolkje T. W. de Jong-van den Berg, Hilde Tobi, How to estimate the population that is covered by community pharmacies? An evaluation of two methods using drug utilisation information Pharmacoepidemiology and Drug Safety. ,vol. 13, pp. 173- 179 ,(2004) , 10.1002/PDS.882
John A. Oates, Alastair J.J. Wood, J. Christian Gillin, William F. Byerley, Drug therapy: The diagnosis and management of insomnia. The New England Journal of Medicine. ,vol. 322, pp. 239- 248 ,(1990) , 10.1056/NEJM199001253220406
Malcolm Lader, Andre Tylee, John Donoghue, Withdrawing Benzodiazepines in Primary Care CNS Drugs. ,vol. 23, pp. 19- 34 ,(2009) , 10.2165/0023210-200923010-00002